COVID-19 studies for: C19 studies:  HC QHC Q Vitamin DVitamin D IvermectinIVM LY-CoVLY REGN-COV2REGN RemdesivirRMD
HC Q study #79
Source   Share   Tweet
See all 143 studies
7/15
Negative
Late treatment study
Gupta et al., JAMA Intern. Med., doi:10.1001/jamainternmed.2020.3596 (Peer Reviewed)
Factors Associated With Death in Critically Ill Patients With Coronavirus Disease 2019 in the US
Analysis of 2215 intensive care unit patients showing no significant differences with this very late stage use of HC Q. HC Q+AZ mortality relative risk RR 0.96, p=0.53, HC Q and HC Q+AZ combined RR 1.06, p=0.409.
death, ↑6.0%, p=0.41
Source   Share   Tweet
See all 143 studies
Please send us corrections, updates, or comments.
Submit